Clinical Trial Update: Carotene and Retinol Efficacy Trial [Phase 4]

View source ↗

Summary

The Carotene and Retinol Efficacy Trial has completed Phase 4 evaluation for lung cancer, assessing carotene and retinol supplementation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Beta-carotene (beta-carotene)
• retinyl palmitate (retinyl palmitate)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Lung Cancer | Phase 4 | Status: COMPLETED